153 related articles for article (PubMed ID: 30508188)
1. Co-operative groups in the development of chemotherapy for gastric cancer.
Arai H; Sunakawa Y; Nakajima TE
Jpn J Clin Oncol; 2019 Mar; 49(3):210-227. PubMed ID: 30508188
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
3. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
Leong T; Smithers BM; Michael M; Gebski V; Boussioutas A; Miller D; Simes J; Zalcberg J; Haustermans K; Lordick F; Schuhmacher C; Swallow C; Darling G; Wong R
BMC Cancer; 2015 Jul; 15():532. PubMed ID: 26194186
[TBL] [Abstract][Full Text] [Related]
4. Recent insights in the therapeutic management of patients with gastric cancer.
de Mestier L; Lardière-Deguelte S; Volet J; Kianmanesh R; Bouché O
Dig Liver Dis; 2016 Sep; 48(9):984-94. PubMed ID: 27156069
[TBL] [Abstract][Full Text] [Related]
5. A systematic overview of chemotherapy effects in gastric cancer.
Janunger KG; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):309-26. PubMed ID: 11441938
[TBL] [Abstract][Full Text] [Related]
6. A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).
Kataoka K; Tokunaga M; Mizusawa J; Machida N; Katayama H; Shitara K; Tomita T; Nakamura K; Boku N; Sano T; Terashima M; Sasako M;
Jpn J Clin Oncol; 2015 Nov; 45(11):1082-6. PubMed ID: 26355164
[TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of gastric cancer.
Ilson DH
Curr Opin Gastroenterol; 2018 Nov; 34(6):465-468. PubMed ID: 30303856
[TBL] [Abstract][Full Text] [Related]
8. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.
Lise M; Nitti D; Marchet A; Sahmoud T; Buyse M; Duez N; Fiorentino M; Dos Santos JG; Labianca R; Rougier P
J Clin Oncol; 1995 Nov; 13(11):2757-63. PubMed ID: 7595735
[TBL] [Abstract][Full Text] [Related]
9. Perspectives for personalization in chemotherapy of advanced gastric cancer.
Boku N
Discov Med; 2010 Feb; 9(45):84-9. PubMed ID: 20193632
[TBL] [Abstract][Full Text] [Related]
10. Molecular-targeted therapy for chemotherapy-refractory gastric cancer: a case report and literature review.
Kuo HY; Yeh KH
Anticancer Res; 2014 Jul; 34(7):3695-9. PubMed ID: 24982389
[TBL] [Abstract][Full Text] [Related]
11. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.
Choi AH; Kim J; Chao J
World J Gastroenterol; 2015 Jun; 21(24):7343-8. PubMed ID: 26139980
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin in perioperative chemotherapy for gastric and gastroesophageal junction (GEJ) adenocarcinoma.
Fritsch R; Hoeppner J
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):285-291. PubMed ID: 30791774
[TBL] [Abstract][Full Text] [Related]
13. [Current status and research progress of perioperative chemotherapy in advanced gastric cancer].
Liu N; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):983-5. PubMed ID: 26499140
[TBL] [Abstract][Full Text] [Related]
14. Targetting esophageal and gastric cancers with monoclonal antibodies.
Norguet E; Dahan L; Seitz JF
Curr Top Med Chem; 2012; 12(15):1678-82. PubMed ID: 22978338
[TBL] [Abstract][Full Text] [Related]
15. [Present state and prospects of adjuvant chemotherapy for gastric cancer].
Hori T; Ozawa R; Hanayama H; Yamashita H; Kaibe N; Matsumoto T; Oshima T; Takemura M; Kikuchi S; Sasako M
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1390-5. PubMed ID: 21918333
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Paclitaxel + Ramucirumab Combination Therapy for Advanced Gastric Cancer Progressing After First-line Chemotherapy in Japan.
Saito S; Muneoka Y; Ishikawa T; Akazawa K
Clin Ther; 2017 Dec; 39(12):2380-2388. PubMed ID: 29175097
[TBL] [Abstract][Full Text] [Related]
17. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
Yu W
Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
[TBL] [Abstract][Full Text] [Related]
18. [HER2 and gastric cancer: a novel therapeutic target for trastuzumab].
Bouché O; Penault-Llorca F
Bull Cancer; 2010 Dec; 97(12):1429-40. PubMed ID: 21134821
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the treatment of gastric cancer.
Sun W; Haller DG
Drugs; 2001; 61(11):1545-51. PubMed ID: 11577792
[TBL] [Abstract][Full Text] [Related]
20. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States.
Ohtsu A; Sasako M
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S101-4. PubMed ID: 16399444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]